Tci Wealth Advisors, Inc. Vbi Vaccines Inc Transaction History

Tci Wealth Advisors, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 24, 2022	SELL	$2.21 - $3.22 $1,463 - $2,131	-662 Reduced 2.16%	30,000 $70,000
Q2 2021 Aug 02, 2021	BUY	$2.61 - $4.17 $1,727 - $2,760	662 Added 2.21%	30,662 $103,000
Q2 2020 Jul 20, 2020	BUY	$0.87 - $3.13 $4,350 - $15,650	5,000 Added 20.0%	30,000 $93,000
Q3 2019 Oct 17, 2019	BUY	$0.47 - $1.05 $7,050 - $15,750	15,000 Added 150.0%	25,000 $12,000
Q4 2017 Feb 01, 2018	BUY	$3.29 - $5.03 $32,900 - $50,300	10,000	10,000 $43,000

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.